Literature DB >> 17337777

Dendritic cell immunotherapy for autoimmune diabetes.

Maryam Feili-Hariri1, Rafael R Flores, A Cecilia Vasquez, Penelope A Morel.   

Abstract

Dendritic cells (DC) play important roles in the initiation of immune responses and maintenance of self-tolerance. We have been studying the role of DC in the pathogenesis of type 1 diabetes and exploring the ability of specific DC subsets to prevent diabetes in non-obese diabetic (NOD) mice. DC subsets that prevent diabetes in this model have a mature phenotype and induce the production of regulatory Th2 cells. We review here recent advances in this area and highlight the importance of optimizing culture conditions and purification methods in the isolation of therapeutic DC.

Entities:  

Mesh:

Year:  2006        PMID: 17337777     DOI: 10.1385/IR:36:1:167

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  36 in total

1.  Cytometric and functional analyses of NK and NKT cell deficiencies in NOD mice.

Authors:  L D Poulton; M J Smyth; C G Hawke; P Silveira; D Shepherd; O V Naidenko; D I Godfrey; A G Baxter
Journal:  Int Immunol       Date:  2001-07       Impact factor: 4.823

2.  Inducing and expanding regulatory T cell populations by foreign antigen.

Authors:  Karsten Kretschmer; Irina Apostolou; Daniel Hawiger; Khashayarsha Khazaie; Michel C Nussenzweig; Harald von Boehmer
Journal:  Nat Immunol       Date:  2005-10-23       Impact factor: 25.606

3.  Elevated NF-kappaB activation in nonobese diabetic mouse dendritic cells results in enhanced APC function.

Authors:  Brian Poligone; Donald J Weaver; Pradip Sen; Albert S Baldwin; Roland Tisch
Journal:  J Immunol       Date:  2002-01-01       Impact factor: 5.422

Review 4.  Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat.

Authors:  L Castaño; G S Eisenbarth
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

5.  Prevention of spontaneous autoimmune diabetes in NOD mice by transferring in vitro antigen-pulsed syngeneic dendritic cells.

Authors:  G Papaccio; F Nicoletti; F A Pisanti; K Bendtzen; M Galdieri
Journal:  Endocrinology       Date:  2000-04       Impact factor: 4.736

6.  Complete suppression of insulitis and diabetes in NOD mice lacking interferon regulatory factor-1.

Authors:  T Nakazawa; J Satoh; K Takahashi; Y Sakata; F Ikehata; Y Takizawa; S I Bando; T Housai; Y Li; C Chen; T Masuda; S Kure; I Kato; S Takasawa; T Taniguchi; H Okamoto; T Toyota
Journal:  J Autoimmun       Date:  2001-09       Impact factor: 7.094

7.  Antisense oligonucleotides down-regulating costimulation confer diabetes-preventive properties to nonobese diabetic mouse dendritic cells.

Authors:  Jennifer Machen; Jo Harnaha; Robert Lakomy; Alexis Styche; Massimo Trucco; Nick Giannoukakis
Journal:  J Immunol       Date:  2004-10-01       Impact factor: 5.422

8.  Dendritic cells transduced to express interleukin-4 prevent diabetes in nonobese diabetic mice with advanced insulitis.

Authors:  Maryam Feili-Hariri; Dewayne H Falkner; Andrea Gambotto; Glenn D Papworth; Simon C Watkins; Paul D Robbins; Penelope A Morel
Journal:  Hum Gene Ther       Date:  2003-01-01       Impact factor: 5.695

9.  Regulatory Th2 response induced following adoptive transfer of dendritic cells in prediabetic NOD mice.

Authors:  Maryam Feili-Hariri; Dewayne H Falkner; Penelope A Morel
Journal:  Eur J Immunol       Date:  2002-07       Impact factor: 5.532

10.  CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes.

Authors:  Kristin V Tarbell; Sayuri Yamazaki; Kara Olson; Priscilla Toy; Ralph M Steinman
Journal:  J Exp Med       Date:  2004-06-07       Impact factor: 14.307

View more
  7 in total

Review 1.  Tolerogenic dendritic cells and their potential applications.

Authors:  Jim Hu; Yonghong Wan
Journal:  Immunology       Date:  2011-01-05       Impact factor: 7.397

2.  A short pulse of IL-4 delivered by DCs electroporated with modified mRNA can both prevent and treat autoimmune diabetes in NOD mice.

Authors:  Rémi J Creusot; Pearl Chang; Don G Healey; Irina Y Tcherepanova; Charles A Nicolette; C Garrison Fathman
Journal:  Mol Ther       Date:  2010-07-13       Impact factor: 11.454

Review 3.  Mouse models for the study of autoimmune type 1 diabetes: a NOD to similarities and differences to human disease.

Authors:  John P Driver; David V Serreze; Yi-Guang Chen
Journal:  Semin Immunopathol       Date:  2010-04-28       Impact factor: 9.623

4.  Designing the optimal vaccine: the importance of cytokines and dendritic cells.

Authors:  Penelope A Morel; Michael S Turner
Journal:  Open Vaccine J       Date:  2010

5.  An alpha-galactosylceramide C20:2 N-acyl variant enhances anti-inflammatory and regulatory T cell-independent responses that prevent type 1 diabetes.

Authors:  D Ly; R Tohn; B Rubin; H Blumenfeld; G S Besra; N Veerapen; S A Porcelli; T L Delovitch
Journal:  Clin Exp Immunol       Date:  2009-12-15       Impact factor: 4.330

6.  Dominant role of antigen dose in CD4+Foxp3+ regulatory T cell induction and expansion.

Authors:  Michael S Turner; Lawrence P Kane; Penelope A Morel
Journal:  J Immunol       Date:  2009-10-15       Impact factor: 5.422

Review 7.  Dendritic cell subsets in type 1 diabetes: friend or foe?

Authors:  Penelope A Morel
Journal:  Front Immunol       Date:  2013-12-06       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.